This study is accepting new patients by invitation only
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Summary
- Eligibility
- for people ages 18-69 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Timothy Henrich, MD (ucsf)Michael Peluso, MD (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientists at University of California Health
- Timothy Henrich, MD (ucsf)
My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs. - Michael Peluso, MD (ucsf)
I am an infectious disease clinical-translational physician-scientist. My primary interests are HIV and COVID-19. I am involved with clinical and laboratory research aimed at understanding the HIV reservoir and implementing clinical trials to disrupt the reservoir with the aim of inducing antiretroviral therapy-free HIV remission.
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Timothy Henrich
- ID
- NCT06161688
- Phase
- Phase 2 COVID-19 Research Study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated